Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment-Reference-Cited by-同舟云学术

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment

Published:2023-09 Issue: Volume:30 Page:86-102
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Xia Baijin,Lin Keming,Wang Xuemei,Chen FeiLi,Zhou Mo,Li Yuzhuang,Lin Yingtong,Qiao Yidan,Li Rong,Zhang Wanying,He Xin,Zou Fan,Li Linghua,Lu Lijuan,Chen Cancan,Li WenYu,Zhang Hui,Liu Bingfeng^ORCID

Funder

National Natural Science Foundation of China

Guangdong Provincial People's Hospital

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference70 articles.

1. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues;Cazzola;Blood,2016

2. Differences in incidence and trends of haematological malignancies in Japan and the United States;Chihara;Br. J. Haematol.,2014

3. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Teras;CA. Cancer J. Clin.,2016

4. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project;Bellei;Haematologica,2018

5. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma;Chihara;Br. J. Haematol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges;Molecular Biotechnology;2024-09-02

2. Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy;Journal of Biomedical Nanotechnology;2024-08-01

3. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy;Molecular Oncology;2024-03-08

4. Advancing Cancer Immune Cell Therapies via Engineered iPSC-Based Strategies;Interdisciplinary Cancer Research;2024

5. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27